NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE193743 Query DataSets for GSE193743
Status Public on Jan 20, 2022
Title A High-Resolution Route Map Reveals Distinct Stages of Chondrocyte Dedifferentiation (ATAC-Seq)
Organism Mus musculus
Experiment type Genome binding/occupancy profiling by high throughput sequencing
Summary Objectives: Articular cartilage damage has become a universal health burden. Despite the recent progresses in cell-based cartilage regeneration, chondrocyte dedifferentiation has compromised the clinical outcomes, which is frequently seen in chondrocyte expansion and osteoarthritis, involving functional phenotype loss. However, its concept remains elusive with unknown intermediate process and mechanisms. Here we demonstrated a time-lapse atlas of chondrocyte dedifferentiation, to provide molecular details and informative biomarkers for clinical chondrocyte evaluation.
Methods: Single-cell RNA sequencing (scRNA-seq) was employed to dissect the chondrocyte dedifferentiation and identify distinct cellular subpopulations. To validate the findings, live-cell metabolic assay, high-resolution imaging and ¡°assay for transposase-accessible chromatin with high throughput sequencing¡± (ATAC-seq) were conducted. Using a chemical inhibitor BTB06584 affecting on mitochondrial F1F0ATPase, we revealed the recovery potential of early and late dedifferentiated chondrocytes.
Results:Our findings shape a biphasic model consist of early and late dedifferentiation stages. Early dedifferentiated chondrocytes uniquely obtained a transient glycolytic phenotype with an activation of metabolic and anti-oxidant genes; late dedifferentiated chondrocytes exhibited ultrastructural changes including mitochondrion damages and stress-associated chromatin remodeling. Using a chemical inhibitor BTB06584, we revealed that early and late dedifferentiated chondrocytes possessed distinguished recovery potential from functional phenotype loss. BTB06584 treatment ameliorated early phenotype loss through inhibiting MAPK pathway. Notably, this two-stage transition was validated in human chondrocyte culture. An image-based approach was established for clinical utilization, to efficiently predict chondrocytes plasticity with stage-specific biomarkers.
Conclusion: Thus this study lays a foundation for future clinical chondrocyte quality regulation and provides insights for deeper understanding of chondrocyte dedifferentiation.
 
Overall design We employed ATAC-seq of serial-passaged murine chondrocytes (P0 and 8) to reconstruct a time-lapse atlas of chondrocyte dedifferentiation.
 
Contributor(s) Chen Y, Yu Y
Citation(s) 35477573
Submission date Jan 14, 2022
Last update date May 03, 2022
Contact name Yishan Chen
E-mail(s) YishanChen@intl.zju.edu.cn
Organization name Zhejiang University
Street address #866 Yuhangtang Road
City Hangzhou
ZIP/Postal code 310058
Country China
 
Platforms (1)
GPL21273 HiSeq X Ten (Mus musculus)
Samples (4)
GSM5820415 P0_1
GSM5820416 P0_2
GSM5820417 P8_1
This SubSeries is part of SuperSeries:
GSE193744 A High-Resolution Route Map Reveals Distinct Stages of Chondrocyte Dedifferentiation
Relations
BioProject PRJNA797450

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE193743_processed_data-2.csv.gz 6.6 Mb (ftp)(http) CSV
GSE193743_processed_data-3.csv.gz 4.8 Mb (ftp)(http) CSV
GSE193743_processed_data-4.csv.gz 400.1 Kb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap